I
106TH CONGRESS
1ST SESSION
H. R. 2130
To amend the Controlled Substances Act to add gamma hydroxybutyric acid
and ketamine to the schedules of control substances, to provide for
a national awareness campaign, and for other purposes.
IN THE HOUSE OF REPRESENTATIVES
JUNE 10, 1999
Mr. UPTON (for himself, Mr. STUPAK, Ms. JACKSON-LEE of Texas, and Mr.
BLILEY) introduced the following bill; which was referred to the Com-
mittee on Commerce, and in addition to the Committee on the Judiciary,
for a period to be subsequently determined by the Speaker, in each case
for consideration of such provisions as fall within the jurisdiction of the
committee concerned
A BILL
To amend the Controlled Substances Act to add gamma
hydroxybutyric acid and ketamine to the schedules of
control substances, to provide for a national awareness
campaign, and for other purposes.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ‘‘Hillory J. Farias Date-
Rape Prevention Drug Act of 1999’’.
SEC. 2. FINDINGS.
The Congress finds the following:
(1) Gamma hydroxybutyric acid (also called G,
Liquid X, Ecstasy, Grievous Bodily Harm, Georgia
Home Boy, Scoop) has become a significant and
growing problem in law enforcement. At least 20
States have scheduled such drug in their drug laws
and law enforcement officials have been experiencing
an increased presence of the drug in driving under
the influence, sexual assault, and overdose cases es-
pecially at night clubs and parties.
(2) A behavioral depressant and a hypnotic,
Gamma hydroxybutyric acid is being used in con-
junction with alcohol and other drugs with detri-
mental effects in an increasing number of cases. It
is difficult to isolate the impact of such drug’s inges-
tion since it is so typically taken with an ever-chang-
ing array of other drugs and especially alcohol which
potentiates its impact.
(3) Gamma hydroxybutyric acid takes the same
path as alcohol, processes via alcohol dehydrogenase,
and its symptoms at high levels of intake and as im-
pact builds are comparable to alcohol ingestion/in-
toxication. Thus, aggression and violence can be ex-
pected in some individuals who use such drug.
(b) ADDITION
TO SCHEDULE III.—Schedule III
under section 202(c) of the Controlled Substances Act (21
U.S.C. 812(c)) is amended in (b)—
(1) by redesignating (4) through (10) as (5)
through (11), respectively; and
(2) by inserting after (3) the following:
‘‘(4) Ketamine and its salts, isomers, and salts
of isomers.’’.
(c) ADDITIONAL LIST I CHEMICAL.—Section 102(34)
of the Controlled Substances Act (21 U.S.C. 802(34)) is
amended—
(1) by redesignating subparagraph (X) as sub-
paragraph (Y); and
(2) by inserting after subparagraph (W) the fol-
lowing subparagraph:
‘‘(X) Gamma butyrolactone.’’.
SEC. 4. ANNUAL REPORT REGARDING DATE-RAPE DRUGS;
NATIONAL AWARENESS CAMPAIGN.
(a) ANNUAL REPORT.—The Secretary of Health and
Human Services (in this section referred to as the ‘‘Sec-
retary’’) shall periodically submit to the Congress reports
each of which provides an estimate of the number of inci-
dents of the abuse of date-rape drugs (as defined in sub-
section (c)) that occurred during the most recent one-year
period for which data are available. The first such report
shall be submitted not later than January 15, 2000, and
subsequent reports shall be submitted annually thereafter.
(b) NATIONAL AWARENESS CAMPAIGN.—
(1) DEVELOPMENT
OF
PLAN; RECOMMENDA-
TIONS OF ADVISORY COMMITTEE.—
(A) IN GENERAL.—The Secretary, in con-
sultation with the Attorney General, shall de-
velop a plan for carrying out a national cam-
paign to educate individuals described in sub-
paragraph (B) on the following:
(i) The dangers of date-rape drugs.
(ii) The applicability of the Controlled
Substances Act to such drugs, including
penalties under such Act.
(iii) Recognizing the symptoms that
indicate an individual may be a victim of
such drugs, including symptoms with re-
spect to sexual assault.
(iv) Appropriately responding when an
individual has such symptoms.
(B) INTENDED POPULATION.—The individ-
uals referred to in subparagraph (A) are young
adults, youths, law enforcement personnel, edu-
cators, school nurses, counselors of rape vic-
tims, and emergency room personnel in hos-
pitals.
(C) ADVISORY
COMMITTEE.—Not later
than 180 days after the date of the enactment
of this Act, the Secretary shall establish an ad-
visory committee to make recommendations to
the Secretary regarding the plan under sub-
paragraph (A). The committee shall be com-
posed of individuals who collectively possess ex-
pertise on the effects of date-rape drugs and on
detecting and controlling the drugs.
(2) IMPLEMENTATION
OF
PLAN.—Not later
than 180 days after the date on which the advisory
committee under paragraph (1) is established, the
Secretary, in consultation with the Attorney General,
shall commence carrying out the national campaign
under such paragraph in accordance with the plan
developed under such paragraph. The campaign may
be carried out directly by the Secretary and through
grants and contracts.
(3) EVALUATION BY GENERAL ACCOUNTING OF-
FICE.—Not later than two years after the date on
which the national campaign under paragraph (1) is
commenced, the Comptroller General of the United
States shall submit to the Congress an evaluation of
the effects with respect to date-rape drugs of the na-
tional campaign.
(c) DEFINITION.—For purposes of this section, the
term ‘‘date-rape drugs’’ means gamma hydroxybutyric
acid and its salts and such other drugs or substances as
the Secretary, after consultation with the Attorney Gen-
eral, determines to be appropriate.
Æ